Canaccord analyst Caitlin Roberts initiated coverage of OrthoPediatrics (KIDS) with a Buy rating and $24 price target
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KIDS:
- OrthoPediatrics expands bracing portfolio with two new product launches
- OrthoPediatrics Corp’s Mixed Earnings Call Review
- OrthoPediatrics price target lowered to $26 from $42 at Needham
- OrthoPediatrics: Buy Rating Affirmed Amidst Growth Potential and Operational Efficiency
- OrthoPediatrics Corp. Reports Strong Q3 2025 Growth